91 related articles for article (PubMed ID: 17524560)
1. A cell model system to study regulation of phosphotidylinositol 3-kinase and protein kinase B activity by cytokines/growth factors produced by type I collagen stimulated immune cells from patients with systemic sclerosis.
Chiang TM; Postlethwaite AE
Biochim Biophys Acta; 2007 Aug; 1770(8):1181-6. PubMed ID: 17524560
[TBL] [Abstract][Full Text] [Related]
2. Increase in phosphotidylinositide-3 kinase activity by nitrotyrosylation of lysates of platelets from patients with systemic sclerosis.
Chiang TM; Postlethwaite AE
Biochim Biophys Acta; 2006 Jan; 1760(1):32-7. PubMed ID: 16271833
[TBL] [Abstract][Full Text] [Related]
3. Alteration in protein kinase B (AKT) activity in platelets from patients with systemic sclerosis.
Chiang TM; Postlethwaite AE
Thromb Res; 2008; 122(4):501-6. PubMed ID: 18355897
[TBL] [Abstract][Full Text] [Related]
4. Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis.
Chiang TM; Takayama H; Postlethwaite AE
Thromb Res; 2006; 117(3):299-306. PubMed ID: 16378833
[TBL] [Abstract][Full Text] [Related]
5. Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts.
Brown M; Postlethwaite AE; Myers LK; Hasty KA
Clin Rheumatol; 2012 Jun; 31(6):973-81. PubMed ID: 22367096
[TBL] [Abstract][Full Text] [Related]
6. Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines.
Ihn H; Sato S; Fujimoto M; Kikuchi K; Kadono T; Tamaki K; Takehara K
Br J Rheumatol; 1997 Dec; 36(12):1270-5. PubMed ID: 9448587
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblasts.
Yamane K; Ihn H; Tamaki K
Arthritis Rheum; 2003 Jun; 48(6):1652-66. PubMed ID: 12794834
[TBL] [Abstract][Full Text] [Related]
9. Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity.
Toulany M; Baumann M; Rodemann HP
Mol Cancer Res; 2007 Aug; 5(8):863-72. PubMed ID: 17699110
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation.
Chen EY; Mazure NM; Cooper JA; Giaccia AJ
Cancer Res; 2001 Mar; 61(6):2429-33. PubMed ID: 11289110
[TBL] [Abstract][Full Text] [Related]
11. Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
Hasegawa M; Sato S; Takehara K
Arch Dermatol Res; 2004 Jul; 296(2):89-93. PubMed ID: 15133694
[TBL] [Abstract][Full Text] [Related]
12. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis.
Park SH; Min DJ; Cho ML; Kim WU; Youn J; Park W; Cho CS; Kim HY
Arthritis Rheum; 2001 Mar; 44(3):561-9. PubMed ID: 11263770
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood mononuclear cells from patients with systemic sclerosis spontaneously secrete increased amounts of vascular endothelial growth factor (VEGF) already in the early stage of the disease.
Bielecki M; Kowal K; Lapinska A; Chwiesko-Minarowska S; Chyczewski L; Kowal-Bielecka O
Adv Med Sci; 2011; 56(2):255-63. PubMed ID: 21983449
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects.
Stirone C; Boroujerdi A; Duckles SP; Krause DN
Mol Pharmacol; 2005 Jan; 67(1):105-13. PubMed ID: 15496504
[TBL] [Abstract][Full Text] [Related]
15. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
16. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.
Gold MR; Scheid MP; Santos L; Dang-Lawson M; Roth RA; Matsuuchi L; Duronio V; Krebs DL
J Immunol; 1999 Aug; 163(4):1894-905. PubMed ID: 10438924
[TBL] [Abstract][Full Text] [Related]
17. Diminished production of TWEAK by the peripheral blood mononuclear cells is associated with vascular involvement in patients with systemic sclerosis.
Bielecki M; Kowal K; Lapinska A; Chwiecko J; Skowronski J; Sierakowski S; Chyczewski L; Kowal-Bielecka O
Folia Histochem Cytobiol; 2009 Jan; 47(3):465-9. PubMed ID: 20164033
[TBL] [Abstract][Full Text] [Related]
18. Anti-fibrotic characteristics of Vγ9+ γδ T cells in systemic sclerosis.
Markovits N; Bendersky A; Loebstein R; Brusel M; Kessler E; Bank I
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):23-29. PubMed ID: 26886502
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast proliferation by bleomycin stimulated peripheral blood mononuclear cell factors.
Yamamoto T; Katayama I; Nishioka K
J Rheumatol; 1999 Mar; 26(3):609-15. PubMed ID: 10090171
[TBL] [Abstract][Full Text] [Related]
20. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
